Correlation Between NYSE Composite and Galectin Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Galectin Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Galectin Therapeutics.
Diversification Opportunities for NYSE Composite and Galectin Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NYSE and Galectin is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Galectin Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Galectin Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 1.37 times less return on investment than Galectin Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 4.76 times less risky than Galectin Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Galectin Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 275.00 in Galectin Therapeutics on August 30, 2024 and sell it today you would earn a total of 9.00 from holding Galectin Therapeutics or generate 3.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Galectin Therapeutics
Performance |
| Timeline |
NYSE Composite and Galectin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Galectin Therapeutics
Pair trading matchups for Galectin Therapeutics
Pair Trading with NYSE Composite and Galectin Therapeutics
The main advantage of trading using opposite NYSE Composite and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.| NYSE Composite vs. Delek Drilling | NYSE Composite vs. Helmerich and Payne | NYSE Composite vs. Waste Management | NYSE Composite vs. US Global Investors |
| Galectin Therapeutics vs. Madrigal Pharmaceuticals | Galectin Therapeutics vs. Viking Therapeutics | Galectin Therapeutics vs. Sarepta Therapeutics | Galectin Therapeutics vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |